Markets
CI

Company News For Aug 3, 2018

  • Cigna Corporation's CI shares jumped 3.3% after the company reported second-quarter fiscal 2018 adjusted earnings of $3.89 per share, beating the Zacks Consensus Estimate of $3.33 per share
  • Shares of Tesla, Inc. TSLA surged 16.2% after the company reported second-quarter fiscal 2018 revenues of $4 billion, surpassing the Zacks Consensus Estimate of $3.8 billion
  • Teva Pharmaceutical Industries Limited's TEVA shares declined 9.5% after the company reported second-quarter fiscal 2018 revenues of $4.70 billion, missing the Zacks Consensus Estimate of $4.76 billion
  • Shares of Regeneron Pharmaceuticals, Inc. REGN increased 7% after the company reported second-quarter fiscal 2018 adjusted earnings of $0.77 per share, surpassing the Zacks Consensus Estimate of $0.71 per share

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Tesla, Inc. (TSLA): Free Stock Analysis Report

Cigna Corporation (CI): Free Stock Analysis Report

Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report

Teva Pharmaceutical Industries Ltd. (TEVA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CI REGN TSLA TEVA

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More